Behbahani Ali's Form 4 filing
Black Diamond Therapeutics, Inc. (BDTX) · filed Sep 21, 2026
- Accession no.
- 0001193125-26-396868
- Filed
- Sep 21, 2026, 5:45 PM ET
- Trade date
- Sep 18, 2026
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Behbahani AliCIK 0001613867 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 18, 2026 | Common Stock | AGrant or awardAcquired | +7,707 | $1.93F2 | +$14,874.51 | 110,236 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on September 17, 2026.
Referenced by the price of 1 transaction in Table I.